Circio partners with 4basebio to develop synthetic “circVec” DNA vectors for in vivo gene therapy delivery. The collaboration ...
The European Commission (EC) has approved a Marketing Authorization (MA) for Lazcluze (lazertinib), in combination with ...
Donald Trump formally withdraws the USA from the WHO, citing mismanagement of the COVID-19 pandemic and financial disparities ...
China’s Junshi Biosciences yesterday revealed that its wholly-owned subsidiary TopAlliance Bioscience has entered into a ...
Dutch biotech Pharming Group today announced that its board of directors has nominated Fabrice Chouraqui to become the ...
French pharma major Sanofi’s consumer healthcare business, Opella, has announced that the US Food and Drug Administration ...
Fermion Technology partners with Simcere Pharmaceutical to develop and commercialise FZ002-037, a clinical-stage non-opioid ...
Novartis sues HHS over rejection of a proposed 340B rebate model, arguing it enhances transparency and compliance while ...
Numbers of ongoing advanced therapy clinical trials in the UK reached 187 in 2024, an increase of 7% compared to the previous ...
In what it describes as a significant step forward for India’s cancer treatment, India’s cell and gene therapy start-up ...
The European Commission has approved Jemperli (dostarlimab) in combination with chemotherapy (carboplatin and paclitaxel) for ...
Orexo converts royalty rights from vipoglanstat into Gesynta Pharma shares valued at 19.2M kroner, following Gesynta’s capital raise. Gesynta will fund a Phase II trial of vipoglanstat, a promising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback